Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Meijer, Adam"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 41
Tytuł:
Delineating immune variation between adult and children COVID-19 cases and associations with disease severity.
Autorzy:
Cevirgel A; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Vos M; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Holtrop AF; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Beckers L; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Reukers DFM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Meijer A; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Rots N; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van Beek J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van Baarle D; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Medical Microbiology and Infection Prevention, Virology and Immunology Research Group, University Medical Center Groningen, Groningen, The Netherlands.
de Wit J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 01; Vol. 14 (1), pp. 5090. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Adult ; Child ; Humans ; SARS-CoV-2 ; B-Lymphocytes ; Kinetics ; Patient Acuity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High quality of SARS-CoV-2 molecular diagnostics in a diverse laboratory landscape through supported benchmark testing and External Quality Assessment.
Autorzy:
Sluimer J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van den Akker WMR; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Goderski G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Swart A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van der Veer B; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Cremer J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Chung NH; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Molenkamp R; Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Voermans J; Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Guldemeester J; Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eggink D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Presser LD; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Meijer A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Adam.Meijer@rivm.nl.
Pokaż więcej
Corporate Authors:
Working Group SARS-CoV-2 Diagnostics The Netherlands
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1378. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*/diagnosis
COVID-19*/epidemiology
Humans ; Laboratories ; Clinical Laboratory Techniques/methods ; COVID-19 Testing ; Benchmarking ; Pathology, Molecular ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Autorzy:
Maurel M; Epiconcept Paris France.
Pozo F; National Centre for Microbiology Institute of Health Carlos III Madrid Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.
Pérez-Gimeno G; National Centre for Microbiology Institute of Health Carlos III Madrid Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.
Buda S; Department for Infectious Disease Epidemiology, Respiratory Infections Unit Robert Koch Institute Berlin Germany.
Sève N; Sorbonne Université INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136) Paris France.
Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Hooiveld M; Nivel Utrecht the Netherlands.
Gomez V; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
Domegan L; HSE-Health Protection Surveillance Centre Dublin Ireland.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Ilić M; Croatian Institute of Public Health Zagreb Croatia.
Carnahan AS; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Mihai ME; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Martínez A; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública de Catalunya Barcelona Spain.
Goerlitz L; Department for Infectious Disease Epidemiology, Respiratory Infections Unit Robert Koch Institute Berlin Germany.
Enouf V; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur Paris France.
Horváth JK; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Dijkstra F; National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands.
Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
Bennett C; National Virus Reference Laboratory University College Dublin Dublin Ireland.
Trobajo-Sanmartín C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Mlinarić I; Croatian Institute of Public Health Zagreb Croatia.
Latorre-Margalef N; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Ivanciuc A; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Lopez A; Subdirección General de Epidemiologia y Vigilancia de la Salud Valencia Spain.
Dürrwald R; National Reference Centre for Influenza Robert Koch Institute Berlin Germany.
Falchi A; Laboratoire de Virologie Université de Corse-Inserm Corte France.
Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre Semmelweis University Budapest Hungary.
Meijer A; National Institute for Public Health and the Environment (RIVM) Bilthoven the Netherlands.
Melo A; Instituto Nacional de Saúde Dr. Ricardo Jorge Lisbon Portugal.
O'Donnell J; HSE-Health Protection Surveillance Centre Dublin Ireland.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) Madrid Spain.; Instituto de Salud Pública de Navarra (IdiSNA) Pamplona Spain.
Vučina VV; Croatian Institute of Public Health Zagreb Croatia.
Hagey TS; The Public Health Agency of Sweden (PHAS) Stockholm Sweden.
Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development Bucharest Romania.
Kaczmarek M; European Centre for Disease Prevention and Control Stockholm Sweden.
Bacci S; European Centre for Disease Prevention and Control Stockholm Sweden.
Kissling E; Epiconcept Paris France.
Pokaż więcej
Corporate Authors:
VEBIS study team
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jan 10; Vol. 18 (1), pp. e13243. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Influenza A virus*
Influenza A Virus, H1N1 Subtype*/genetics
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Child ; Humans ; Europe/epidemiology ; Influenza A Virus, H3N2 Subtype/genetics ; Primary Health Care ; Vaccine Efficacy ; Infant, Newborn ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Adult ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Autorzy:
Meslé MMI; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
Sinnathamby M; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
Mook P; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
Pebody R; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
Lakhani A; UK Health Security Agency London UK.
Zambon M; UK Health Security Agency London UK.
Popovici O; National Institute of Public Health Bucharest Romania.
Lazăr M; Cantacuzino National Military-Medical Institute for Research and Development Bucharest Romania.
Ljubović AD; Clinical Center University of Sarajevo Sarajevo Bosnia and Herzegovina.
Vukmir NR; Public Health Institute of the Republic of Srpska Banja Luka Bosnia and Herzegovina.; Faculty of Medicine University of Banja Luka Banja Luka Bosnia and Herzegovina.
Altaş AB; General Directorate of Public Health Ankara Türkiye.
Avci E; General Directorate of Public Health Ankara Türkiye.
Łuniewska K; National Research Institute Warsaw Poland.
Szymański K; National Research Institute Warsaw Poland.
Gargasiene G; National Public Health Center under the Ministry of Health Vilnius Lithuania.
Muralyte S; National Public Health Surveillance Laboratory Vilnius Lithuania.
Dziugyte A; Ministry for Health Regulation Pieta Malta.
Zahra G; Ministry for Health Regulation Pieta Malta.
Gonçalves AR; University of Geneva Hospitals Geneva Switzerland.
Spedaliero T; University of Geneva Hospitals Geneva Switzerland.
Fournier G; Laboratoire National de Santé Dudelange Luxembourg.
Alvarez-Vaca D; Laboratoire National de Santé Dudelange Luxembourg.
Petrović G; Croatian Institute of Public Health Zagreb Croatia.
Tabain I; Croatian Institute of Public Health Zagreb Croatia.
Prosenc K; National Laboratory of Health, Environment and Food Ljubljana Slovenia.
Socan M; National Institute of Public Health Ljubljana Slovenia.
Protic J; Institute of Virology, Vaccines and Sera Torlak Belgrade Serbia.
Dimitrijevic D; Institute of Public Health of Serbia Belgrade Serbia.
Druc A; National Agency for Public Health Chişinău Republic of Moldova.
Apostol M; National Agency for Public Health Chişinău Republic of Moldova.
Kalasnikova KK; Centre for Disease Prevention and Control Riga Latvia.
Nikisins S; Riga East University Hospital Riga Latvia.
Reiche J; Robert Koch Institute Berlin Germany.
Cai W; Robert Koch Institute Berlin Germany.
Meijer A; Centre for Infectious Disease Control Bilthoven The Netherlands.
Teirlinck A; Centre for Infectious Disease Control Bilthoven The Netherlands.
Larrauri A; Carlos III Health Institute Madrid Spain.
Casas I; Carlos III Health Institute Madrid Spain.
Enouf V; Institut Pasteur Paris France.
Vaux S; Santé Publique France Saint-Maurice France.
Lomholt FK; Statens Serum Institute Copenhagen Denmark.
Trebbien R; Statens Serum Institute Copenhagen Denmark.
Jirincova H; National Institute of Public Health Prague Czechia.
Sebestova H; National Institute of Public Health Prague Czechia.
Rózsa M; National Public Health Center Budapest Hungary.
Molnár Z; National Public Health Center Budapest Hungary.
Aspelund G; The Directorate of Health Reykjavik Iceland.
Baldvinsdottir GE; The National University Hospital of Iceland Reykjavik Iceland.
Cottrell S; Public Health Wales Cardiff UK.
Moore C; Public Health Wales Cardiff UK.
Kossyvakis A; Hellenic Pasteur Institute Athens Greece.
Mellou K; National Public Health Organization Athens Greece.
Sadikova O; The Estonian Health Board Tallinn Estonia.
Tamm JK; The Estonian Health Board Tallinn Estonia.
Bossuyt N; Sciensano Brussels Belgium.
Thomas I; Sciensano Brussels Belgium.
Staroňová E; Public Health Authority of the Slovak Republic Bratislava Slovakia.
Kudasheva L; Sanitary and Epidemiological Welfare and Public Health Service of the Republic of Uzbekistan Toshkent Uzbekistan.
Pleshkov B; Sanitary and Epidemiological Welfare and Public Health Service of the Republic of Uzbekistan Toshkent Uzbekistan.
Ikonen N; Finnish Institute for Health and Welfare Helsinki Finland.
Helve O; Finnish Institute for Health and Welfare Helsinki Finland.
Dickson E; Public Health Agency Belfast UK.
Curran T; Belfast Health and Social Care Trust Belfast UK.
Komissarova K; Smorodintsev Research Institute of Influenza St Petersburg Russian Federation.
Stolyarov K; Smorodintsev Research Institute of Influenza St Petersburg Russian Federation.
Vysotskaya V; Republican Center for Hygiene, Epidemiology and Public Health Minsk Belarus.
Shmialiova N; Republican Research and Practical Center for Epidemiology and Microbiology Minsk Belarus.
Rakočević B; Institute of Public Health of Montenegro Podgorica Montenegro.
Vujošević D; Institute of Public Health of Montenegro Podgorica Montenegro.
Abovyan R; National Center for Disease Control and Prevention Yerevan Armenia.
Sargsyan S; National Center for Disease Control and Prevention Yerevan Armenia.
Zakhashvili K; National Center for Disease Control and Public Health Tbilisi Georgia.
Machablishvili A; National Center for Disease Control and Public Health Tbilisi Georgia.
Koshalko O; Public Health Center of the Ministry of Health of Ukraine Kyiv Ukraine.
Demchyshyna I; Public Health Center of the Ministry of Health of Ukraine Kyiv Ukraine.
Mandelboim M; Israel Ministry of Health Ramat Gan Israel.
Glatman-Freedman A; Israel Ministry of Health Ramat Gan Israel.
Gunson R; West of Scotland Specialist Virology Centre Glasgow UK.
Karanwal S; Public Health Scotland Glasgow UK.
Guiomar R; National Institute of Health Doctor Ricardo Jorge Lisbon Portugal.
Rodrigues AP; National Virus Reference Laboratory Dublin Ireland.
Bennett C; National Virus Reference Laboratory Dublin Ireland.
Domegan L; Health Protection Surveillance Centre Dublin Ireland.
Kalaveshi A; National Institute of Public Health of Kosovo Prishtina Kosovo.
Jakupi X; National Institute of Public Health of Kosovo Prishtina Kosovo.
Ovliyakulova G; Ministry of Health and Medical Industry of Turkmenistan Ashgabat Turkmenistan.
Korsun N; National Center of Infectious and Parasitic Diseases Sofia Bulgaria.
Vladimirova N; National Center of Infectious and Parasitic Diseases Sofia Bulgaria.
Pokaż więcej
Corporate Authors:
WHO European Region Respiratory Network Group
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Nov 20; Vol. 17 (11), pp. e13219. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Respiratory Syncytial Virus, Human*
Respiratory Syncytial Virus Infections*/epidemiology
Humans ; Seasons ; Pandemics ; Population Surveillance ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inference of age-dependent case-fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands.
Autorzy:
McDonald SA; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Teirlinck AC; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Hooiveld M; Nivel Utrecht The Netherlands.
van Asten L; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Meijer A; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
de Lange M; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
van Gageldonk-Lafeber AB; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.
Wallinga J; Centre for Infectious Disease Control National Institute for Public Health and the Environment (RIVM) Bilthoven The Netherlands.; Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jun 19; Vol. 17 (6), pp. e13146. Date of Electronic Publication: 2023 Jun 19 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Humans ; Influenza A Virus, H3N2 Subtype ; Seasons ; Netherlands/epidemiology ; Retrospective Studies ; Bayes Theorem ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Autorzy:
Kissling E; Epiconcept, Paris, France.
Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Martínez-Baz I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Buda S; Robert Koch Institut, Berlin, Germany.
Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Dijkstra F; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Latorre-Margalef N; The Public Health Agency of Sweden, Stockholm, Sweden.
Kurečić Filipović S; Croatian Institute of Public Health, Zagreb, Croatia.
Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania.
Casado I; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Dürrwald R; Robert Koch Institut, Berlin, Germany.
van der Werf S; Unité de Génétique Moléculaire des Virus à ARN, Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Paris, France.; CNR virus des infections respiratoires, Institut Pasteur, Paris, France.
O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Linares Dopido JA; Subdirección de Epidemiología, Dirección General de Salud Pública, Servicio Extremeño de Salud, Extremadura, Spain.
Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Riess M; The Public Health Agency of Sweden, Stockholm, Sweden.
Višekruna Vučina V; Croatian Institute of Public Health, Zagreb, Croatia.
Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Mihai ME; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania.
Castilla J; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Goerlitz L; Robert Koch Institut, Berlin, Germany.
Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France.
Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
Castrillejo D; Servicio de Epidemiología, DGSP, Consejería de Políticas Sociales, Salud Pública y Bienestar Animal, Ciudad Autónoma de Melilla, Melilla, Spain.
Hooiveld M; Nivel, Utrecht, The Netherlands.
Carnahan A; The Public Health Agency of Sweden, Stockholm, Sweden.
Ilić M; Croatian Institute of Public Health, Zagreb, Croatia.
Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Ivanciuc A; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania.
Maurel M; Epiconcept, Paris, France.
Omokanye A; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Valenciano M; Epiconcept, Paris, France.
Pokaż więcej
Corporate Authors:
I-MOVE study team
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jan; Vol. 17 (1), pp. e13069. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Humans ; Case-Control Studies ; Europe/epidemiology ; Influenza A Virus, H3N2 Subtype/genetics ; Primary Health Care ; Vaccination ; Vaccine Efficacy ; Male ; Female ; Infant, Newborn ; Infant ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame.
Autorzy:
Han WGH; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Swart A; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Bonačić Marinović A; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Eggink D; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Reimerink J; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Wijsman LA; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van der Veer B; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van den Brink S; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van den Brandt AM; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Tol S; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Godeke GJ; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Brouwer F; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Hoogerwerf M; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Reukers DFM; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Rots N; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Reusken C; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Meijer A; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Adam.Meijer@rivm.nl.
Pokaż więcej
Corporate Authors:
Dutch F. F. X.-COVID-19 Research Group
Źródło:
Scientific reports [Sci Rep] 2022 May 13; Vol. 12 (1), pp. 7937. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/diagnosis
COVID-19*/epidemiology
SARS-CoV-2*/genetics
Adult ; Antibodies, Viral ; COVID-19 Testing ; Child ; Humans ; RNA, Viral/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults.
Autorzy:
Kaaijk P; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Swaans N; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Nicolaie AM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Bruin JP; Regional Laboratory for Public Health Kennemerland, 2035 RC Haarlem, The Netherlands.
van Boxtel RAJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
de Lange MMA; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Meijer A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Sanders EAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center, 3584 EA Utrecht, The Netherlands.
van Houten MA; Spaarne Academy, Spaarne Gasthuis, 2133 TM Hoofddorp, The Netherlands.
Rots NY; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Luytjes W; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
van Beek J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Apr 12; Vol. 14 (4). Date of Electronic Publication: 2022 Apr 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coinfection*/epidemiology
Coronavirus*
Influenza, Human*
Orthomyxoviridae*
Respiratory Syncytial Virus, Human*
Respiratory Tract Infections*
Virus Diseases*/epidemiology
Aged ; Humans ; Infant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries.
Autorzy:
Staadegaard L; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Caini S; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Wangchuk S; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
Thapa B; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
de Almeida WAF; Department of Immunization and Communicable Diseases, Ministry of Health, Brasilia, Brazil.
de Carvalho FC; Department of Immunization and Communicable Diseases, Ministry of Health, Brasilia, Brazil.
Fasce RA; Subdepartamento Enfermedades Virales, Instituto de Salud Pública de Chile, Santiago, Chile.
Bustos P; Sección Virus Respiratorios, Subdepartamento Enfermedades Virales, Instituto de Salud Publica de Chile, Santiago, Chile.
Kyncl J; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Novakova L; National Reference Laboratory for Influenza and Other Respiratory Viruses, National Institute of Public Health, Prague, Czech Republic.
Caicedo AB; Universidad Agraria del Ecuador, Guayaquil, Ecuador.; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
de Mora Coloma DJ; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
Meijer A; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Hooiveld M; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Huang QS; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Wood T; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Guiomar R; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Rodrigues AP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Lee VJM; Ministry of Health, Singapore.; Saw Swee Hock School of Public Health, Singapore.
Ang LW; Ministry of Health, Singapore.; National Centre for Infectious Diseases, Singapore.
Cohen C; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Moyes J; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Delgado-Sanz C; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Demont C; Sanofi Pasteur, Lyon, France.
Bangert M; Sanofi Pasteur, Lyon, France.
Dückers M; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
van Summeren J; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Paget J; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2021 Nov; Vol. 15 (6), pp. 732-741. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epidemics*
Respiratory Syncytial Virus Infections*/epidemiology
Respiratory Syncytial Virus, Human*
Respiratory Tract Infections*/epidemiology
Humans ; Infant ; Seasons ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Erratum: Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.
Autorzy:
Schijven J
Vermeulen LC
Swart A
Meijer A
Duizer E
de Roda Husman AM
Pokaż więcej
Źródło:
Environmental health perspectives [Environ Health Perspect] 2021 Sep; Vol. 129 (9), pp. 99001. Date of Electronic Publication: 2021 Sep 13.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020.
Autorzy:
Kissling E; Epiconcept, Paris, France.
Hooiveld M; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Brytting M; Public Health Agency of Sweden, Solna, Sweden.
Vilcu AM; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
Sigerson D; Public Health Scotland, Glasgow, Scotland.
Enkirch T; Public Health Agency of Sweden, Solna, Sweden.
Belhillil S; National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, Institut Pasteur, UMR 3568 CNRS, University of Paris, Paris, France.
Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Castilla J; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
William N; Public Health Scotland, Glasgow, Scotland.
Carnahan A; Public Health Agency of Sweden, Solna, Sweden.
Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France.
Hendriksen J; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Casado I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
Murray J; Public Health Scotland, Glasgow, Scotland.
Enouf V; National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, Institut Pasteur, UMR 3568 CNRS, University of Paris, Paris, France.
Dijkstra F; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marques DFP; Epiconcept, Paris, France.; Public Health Scotland, Glasgow, Scotland.
Valenciano M; Epiconcept, Paris, France.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2021 Jul; Vol. 15 (4), pp. 429-438. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*epidemiology
Influenza Vaccines/*administration & dosage
Influenza, Human/*prevention & control
Orthomyxoviridae/*immunology
Vaccination/*statistics & numerical data
COVID-19/diagnosis ; Case-Control Studies ; Europe/epidemiology ; Female ; Humans ; Influenza, Human/diagnosis ; Influenza, Human/epidemiology ; Logistic Models ; Male ; Odds Ratio ; Primary Health Care/organization & administration ; Primary Health Care/statistics & numerical data ; Respiratory Tract Infections/diagnosis ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/prevention & control ; SARS-CoV-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees.
Autorzy:
Caini S; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Paget J; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Spreeuwenberg P; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Korevaar JC; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Hooiveld M; Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 May 28; Vol. 16 (5), pp. e0249883. Date of Electronic Publication: 2021 May 28 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Referral and Consultation*
Influenza Vaccines/*administration & dosage
Influenza, Human/*diagnosis
Pneumonia/*diagnosis
Respiratory Tract Infections/*diagnosis
Adult ; Aged ; Female ; General Practitioners/psychology ; Humans ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Male ; Middle Aged ; Netherlands/epidemiology ; Risk ; Seasons ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Temporal Variations in Respiratory Syncytial Virus Epidemics, by Virus Subtype, 4 Countries.
Autorzy:
Staadegaard L
Meijer A
Rodrigues AP
Huang S
Cohen C
Demont C
van Summeren J
Caini S
Paget J
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2021 May; Vol. 27 (5), pp. 1537-1540.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epidemics*
Respiratory Syncytial Virus Infections*/epidemiology
Respiratory Syncytial Virus, Human*
DNA Viruses ; Humans ; Infant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.
Autorzy:
Schijven J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.; Department of Earth Sciences, Utrecht University, Utrecht, Netherlands.
Vermeulen LC; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Swart A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Meijer A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Duizer E; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
de Roda Husman AM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.
Pokaż więcej
Źródło:
Environmental health perspectives [Environ Health Perspect] 2021 Apr; Vol. 129 (4), pp. 47002. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aerosols*
SARS-CoV-2*
COVID-19/*transmission
Pandemics/*prevention & control
Risk Assessment/*methods
Air Microbiology ; COVID-19/prevention & control ; Cough ; Disease Transmission, Infectious ; Humans ; Singing ; Sneezing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries.
Autorzy:
Staadegaard L; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Caini S; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Wangchuk S; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
Thapa B; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.
de Almeida WAF; Ministry of Health, Brasilia, Brazil.
de Carvalho FC; Ministry of Health, Brasilia, Brazil.
Njouom R; Service de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
Fasce RA; Subdepartamento Enfermedades Virales, Instituto de Salud Pública de Chile, Santiago, Chile.
Bustos P; Sección Virus Respiratorios, Subdepartamento Enfermedades Virales, Instituto de Salud Publica de Chile, Santiago, Chile.
Kyncl J; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Novakova L; National Reference Laboratory for Influenza and Other Respiratory Viruses, National Institute of Public Health, Prague, Czech Republic.
Caicedo AB; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.; Universidad Agraria del Ecuador, Guayaquil, Ecuador.
de Mora Coloma DJ; Instituto Nacional de Investigación en Salud Pública (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
Meijer A; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Hooiveld M; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Huang S; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Wood T; Institute of Environmental Science and Research Limited (ESR), National Centre for Biosecurity and Infectious Disease (NCBID), Upper Hutt, New Zealand.
Guiomar R; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Rodrigues AP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Danilenko D; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation.
Stolyarov K; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation.
Lee VJM; Ministry of Health, Singapore.; Saw Swee Hock School of Public Health, Singapore.
Ang LW; Ministry of Health, Singapore.; National Centre for Infectious Diseases, Singapore.
Cohen C; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Moyes J; Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Delgado-Sanz C; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Le MQ; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Hoang PVM; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Demont C; Sanofi Pasteur, Lyon, France.
Bangert M; Sanofi Pasteur, Lyon, France.
van Summeren J; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Dückers M; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.; ARQ National Psychotrauma Centre, Diemen, the Netherlands.; Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, the Netherlands.
Paget J; Nivel (Netherlands Institute for Health Services Research), Utrecht, the Netherlands.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Mar 30; Vol. 8 (7), pp. ofab159. Date of Electronic Publication: 2021 Mar 30 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands.
Autorzy:
van Asten L
Harmsen CN
Stoeldraijer L
Klinkenberg D
Teirlinck AC
de Lange MMA
Meijer A
van de Kassteele J
van Gageldonk-Lafeber AB
van den Hof S
van der Hoek W
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2021 Feb; Vol. 27 (2), pp. 411-420. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*mortality
Epidemics/*statistics & numerical data
Influenza, Human/*mortality
Humans ; Mortality/trends ; Netherlands/epidemiology ; Orthomyxoviridae ; SARS-CoV-2 ; Seasons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination.
Autorzy:
Mögling R
Meijer A
Berginc N
Bruisten S
Charrel R
Coutard B
Eckerle I
Enouf V
Hungnes O
Korukluoglu G
Kossyvakis T
Mentis A
Molenkamp R
Muradrasoli S
Papa A
Pigny F
Thirion L
van der Werf S
Reusken C
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2020 Aug; Vol. 26 (8), pp. 1944-1946. Date of Electronic Publication: 2020 May 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Artifacts*
Betacoronavirus/*genetics
Clinical Laboratory Techniques/*standards
Coronavirus Infections/*diagnosis
Coronavirus Infections/*epidemiology
Pneumonia, Viral/*diagnosis
Pneumonia, Viral/*epidemiology
Reagent Kits, Diagnostic/*standards
Reverse Transcriptase Polymerase Chain Reaction/*standards
Betacoronavirus/pathogenicity ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/methods ; Coronavirus Envelope Proteins ; Coronavirus Infections/virology ; DNA Primers/analysis ; DNA Primers/chemical synthesis ; DNA Probes/analysis ; DNA Probes/chemical synthesis ; Delayed Diagnosis ; Diagnostic Tests, Routine ; Europe/epidemiology ; Humans ; Laboratories/organization & administration ; Laboratories/standards ; Pandemics ; Pathology, Molecular ; Pneumonia, Viral/virology ; RNA-Dependent RNA Polymerase/genetics ; Reagent Kits, Diagnostic/supply & distribution ; Reverse Transcriptase Polymerase Chain Reaction/statistics & numerical data ; SARS-CoV-2 ; Viral Envelope Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Autorzy:
Rose AMC; Epiconcept, Paris, France.
Kissling E; Epiconcept, Paris, France.
Gherasim A; National Centre of Epidemiology, CIBERESP, Institute of Health Carlos III, Madrid, Spain.
Casado I; Navarra Public Health Institute, IdiSNA-CIBERESP, Pamplona, Spain.
Bella A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Launay O; Inserm, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France.; CIC Cochin Pasteur, université Paris Descartes, Sorbonne Paris Cité, hôpital Cochin, AP-HP, Paris, France.
Lazăr M; National Military-Medical Institute for Research and Development, Bucharest, Romania.
Marbus S; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Kuliese M; Department of Infectious diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Syrjänen R; Finnish Institute for Health and Welfare, Tampere, Finland.
Machado A; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Kurečić Filipović S; Division for epidemiology of communicable diseases, Croatian Institute of Public Health, Zagreb, Croatia.
Larrauri A; National Centre of Epidemiology, CIBERESP, Institute of Health Carlos III, Madrid, Spain.
Castilla J; Navarra Public Health Institute, IdiSNA-CIBERESP, Pamplona, Spain.
Alfonsi V; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Galtier F; Inserm, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France.; CHU de Montpellier, Inserm CIC 1411, Hôpital Saint-Eloi, Montpellier, France.
Ivanciuc A; National Military-Medical Institute for Research and Development, Bucharest, Romania.
Meijer A; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Mickiene A; Department of Infectious diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Ikonen N; Finnish Institute for Health and Welfare, Helsinki, Finland.
Gómez V; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
Lovrić Makarić Z; Division for epidemiology of communicable diseases, Croatian Institute of Public Health, Zagreb, Croatia.
Moren A; Epiconcept, Paris, France.
Valenciano M; Epiconcept, Paris, France.
Pokaż więcej
Corporate Authors:
I-MOVE Hospital study team
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2020 May; Vol. 14 (3), pp. 302-310. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza A Virus, H3N2 Subtype/*immunology
Influenza B virus/*immunology
Influenza Vaccines/*administration & dosage
Influenza, Human/*prevention & control
Aged ; Aged, 80 and over ; Case-Control Studies ; Cross Protection ; Europe/epidemiology ; Female ; Hospitalization ; Humans ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Influenza Vaccines/immunology ; Influenza, Human/epidemiology ; Influenza, Human/therapy ; Influenza, Human/virology ; Male ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/therapy ; Respiratory Tract Infections/virology ; Seasons ; Vaccine Potency
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Publisher Correction: Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus.
Autorzy:
Westerhuis B; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Ten Hulscher H; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Jacobi R; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Beek J; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Koopmans M; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Rimmelzwaan G; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo), Hanover, Germany.
Meijer A; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Binnendijk R; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 20; Vol. 10 (1), pp. 5458. Date of Electronic Publication: 2020 Mar 20.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus.
Autorzy:
Westerhuis B; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Ten Hulscher H; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Jacobi R; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Beek J; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Koopmans M; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Rimmelzwaan G; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine (TiHo), Hanover, Germany.
Meijer A; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Binnendijk R; Centre for Infectious Disease Control (Cib), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Feb 21; Vol. 10 (1), pp. 3152. Date of Electronic Publication: 2020 Feb 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunologic Memory*
B-Lymphocytes/*immunology
Influenza A Virus, H7N7 Subtype/*immunology
Influenza, Human/*immunology
Adolescent ; Adult ; Animals ; Antibodies/chemistry ; Case-Control Studies ; Chickens ; Child ; Child, Preschool ; Epitopes/chemistry ; Female ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Humans ; Influenza in Birds/immunology ; Influenza, Human/virology ; Male ; Middle Aged ; Neutralization Tests ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 41

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies